Adams Brings Mucinex To Pediatric Market; Humibid Launch Slated For March
This article was originally published in The Tan Sheet
Executive Summary
Adams Respiratory Therapeutics will launch a line of cough/cold products for children under the Mucinex brand name by the end of 2006
You may also be interested in...
Adams Delays New Humibid Launches, Mucinex Drives Record Overall Sales
In the midst of strong growth from flagship brand Mucinex, Adams is delaying the launch of new Humibid products to train pharmacists in behind-the-counter sale of the OTC drug
OTC Makers Target Children With Mucinex Mini Melts, Triaminic For Infants
Several OTC manufacturers are focusing on the adolescent and children's markets with product launches planned for the 2006-2007 cough/cold season
Adams Expands OTC Cough Market Presence With Delsym Acquisition
Adams Respiratory Therapeutics intends to aggressively promote Delsym cough suppressant to consumers following its May 24 acquisition of the brand